Understanding how arsenic exposure leads to cancer stem-like cells

Dissecting Nrf2-dependent HIF1a activation mechanism in arsenic-induced cancer stem-like cells

['FUNDING_R01'] · STATE UNIVERSITY NEW YORK STONY BROOK · NIH-10973189

This study is looking at how long-term exposure to arsenic can change normal cells into cancer-like cells, focusing on certain pathways in the body, and it aims to find ways to create better treatments for cancers caused by arsenic.

Quick facts

Phase['FUNDING_R01']
Study typeNih_funding
SexAll
SponsorSTATE UNIVERSITY NEW YORK STONY BROOK (nih funded)
Locations1 site (STONY BROOK, UNITED STATES)
Trial IDNIH-10973189 on ClinicalTrials.gov

What this research studies

This research investigates the mechanisms by which long-term exposure to inorganic arsenic can transform normal cells into cancer stem-like cells (CSCs). It focuses on the activation of specific signaling pathways, particularly Nrf2 and HIF1α, which are believed to play a crucial role in this transformation. By using advanced techniques like ChIP-seq and biochemical assays, the study aims to uncover the metabolic and epigenetic changes that occur in cells exposed to arsenic. This knowledge could help in developing targeted therapies for arsenic-induced cancers.

Who could benefit from this research

Good fit: Ideal candidates for this research are individuals with a history of arsenic exposure, particularly those at risk for lung cancer.

Not a fit: Patients who have not been exposed to arsenic or do not have a related cancer may not benefit from this research.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing or treating cancers associated with arsenic exposure.

How similar studies have performed: While the specific mechanisms of arsenic-induced CSCs are not extensively studied, similar research has shown promising results in understanding cancer stem cell biology.

Where this research is happening

STONY BROOK, UNITED STATES

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.

View on NIH RePORTER →

Conditions: arsenic induced cancer

Last reviewed 2026-05-15 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.